Found: 8
Select item for more details and to access through your institution.
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 2, p. 367, doi. 10.1007/s10555-023-10105-2
- By:
- Publication type:
- Article
Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02099-w
- By:
- Publication type:
- Article
CBMT-34. TARGETING THE RNA-PROCESSING GENE MAGOH AS A NOVEL THERAPY FOR MEDULLOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi40, doi. 10.1093/neuonc/noy148.153
- By:
- Publication type:
- Article
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02027-6
- By:
- Publication type:
- Article
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 273, doi. 10.1093/neuonc/noab135
- By:
- Publication type:
- Article
Projected t-SNE for batch correction.
- Published in:
- Bioinformatics, 2020, v. 36, n. 11, p. 3522, doi. 10.1093/bioinformatics/btaa189
- By:
- Publication type:
- Article
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13657-6
- By:
- Publication type:
- Article